nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorometholone—NR3C1—type 2 diabetes mellitus	0.359	0.633	CbGaD
Fluorometholone—CYP3A4—type 2 diabetes mellitus	0.208	0.367	CbGaD
Fluorometholone—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0491	0.152	CbGbCtD
Fluorometholone—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0438	0.136	CbGbCtD
Fluorometholone—CYP3A4—Glipizide—type 2 diabetes mellitus	0.04	0.124	CbGbCtD
Fluorometholone—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.035	0.109	CbGbCtD
Fluorometholone—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0316	0.0982	CbGbCtD
Fluorometholone—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.024	0.0744	CbGbCtD
Fluorometholone—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.023	0.0713	CbGbCtD
Fluorometholone—CYP3A4—Orlistat—type 2 diabetes mellitus	0.023	0.0713	CbGbCtD
Fluorometholone—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0217	0.0675	CbGbCtD
Fluorometholone—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0162	0.0503	CbGbCtD
Fluorometholone—CYP3A4—Losartan—type 2 diabetes mellitus	0.0148	0.046	CbGbCtD
Fluorometholone—Ocular discomfort—Bromocriptine—type 2 diabetes mellitus	0.00562	0.0924	CcSEcCtD
Fluorometholone—Visual disturbance—Repaglinide—type 2 diabetes mellitus	0.0014	0.0231	CcSEcCtD
Fluorometholone—Glaucoma—Gliclazide—type 2 diabetes mellitus	0.00139	0.0229	CcSEcCtD
Fluorometholone—Visual disturbance—Glipizide—type 2 diabetes mellitus	0.00116	0.0191	CcSEcCtD
Fluorometholone—Viral infection—Gliclazide—type 2 diabetes mellitus	0.00116	0.0191	CcSEcCtD
Fluorometholone—Visual disturbance—Pioglitazone—type 2 diabetes mellitus	0.00111	0.0183	CcSEcCtD
Fluorometholone—Cataract—Gliclazide—type 2 diabetes mellitus	0.0011	0.0181	CcSEcCtD
Fluorometholone—Viral infection—Valsartan—type 2 diabetes mellitus	0.00106	0.0175	CcSEcCtD
Fluorometholone—Visual disturbance—Bromocriptine—type 2 diabetes mellitus	0.000977	0.0161	CcSEcCtD
Fluorometholone—Stinging—Losartan—type 2 diabetes mellitus	0.00096	0.0158	CcSEcCtD
Fluorometholone—Visual disturbance—Glyburide—type 2 diabetes mellitus	0.000893	0.0147	CcSEcCtD
Fluorometholone—Visual impairment—Repaglinide—type 2 diabetes mellitus	0.000886	0.0146	CcSEcCtD
Fluorometholone—Eye disorder—Repaglinide—type 2 diabetes mellitus	0.000859	0.0141	CcSEcCtD
Fluorometholone—Conjunctivitis—Glipizide—type 2 diabetes mellitus	0.000824	0.0135	CcSEcCtD
Fluorometholone—Cataract—Losartan—type 2 diabetes mellitus	0.000817	0.0134	CcSEcCtD
Fluorometholone—Eye disorder—Rosiglitazone—type 2 diabetes mellitus	0.000812	0.0134	CcSEcCtD
Fluorometholone—Visual disturbance—Gliclazide—type 2 diabetes mellitus	0.000802	0.0132	CcSEcCtD
Fluorometholone—Visual impairment—Glipizide—type 2 diabetes mellitus	0.000733	0.0121	CcSEcCtD
Fluorometholone—Eye disorder—Glipizide—type 2 diabetes mellitus	0.000711	0.0117	CcSEcCtD
Fluorometholone—Visual impairment—Pioglitazone—type 2 diabetes mellitus	0.000702	0.0115	CcSEcCtD
Fluorometholone—Visual impairment—Glimepiride—type 2 diabetes mellitus	0.000684	0.0112	CcSEcCtD
Fluorometholone—Eye disorder—Pioglitazone—type 2 diabetes mellitus	0.000681	0.0112	CcSEcCtD
Fluorometholone—Eye disorder—Sitagliptin—type 2 diabetes mellitus	0.000661	0.0109	CcSEcCtD
Fluorometholone—Prednisone—HSD11B1—type 2 diabetes mellitus	0.000656	0.0881	CrCbGaD
Fluorometholone—Visual disturbance—Irbesartan—type 2 diabetes mellitus	0.000633	0.0104	CcSEcCtD
Fluorometholone—Rash—Miglitol—type 2 diabetes mellitus	0.000628	0.0103	CcSEcCtD
Fluorometholone—Dermatitis—Miglitol—type 2 diabetes mellitus	0.000627	0.0103	CcSEcCtD
Fluorometholone—Vision blurred—Glipizide—type 2 diabetes mellitus	0.000624	0.0103	CcSEcCtD
Fluorometholone—Visual impairment—Bromocriptine—type 2 diabetes mellitus	0.000617	0.0101	CcSEcCtD
Fluorometholone—Eye disorder—Bromocriptine—type 2 diabetes mellitus	0.000598	0.00984	CcSEcCtD
Fluorometholone—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.000594	0.00977	CcSEcCtD
Fluorometholone—Vision blurred—Glimepiride—type 2 diabetes mellitus	0.000582	0.00958	CcSEcCtD
Fluorometholone—Vision blurred—Sitagliptin—type 2 diabetes mellitus	0.000581	0.00955	CcSEcCtD
Fluorometholone—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.000577	0.00948	CcSEcCtD
Fluorometholone—Conjunctivitis—Gliclazide—type 2 diabetes mellitus	0.000569	0.00936	CcSEcCtD
Fluorometholone—Rash—Tolbutamide—type 2 diabetes mellitus	0.000565	0.00928	CcSEcCtD
Fluorometholone—Visual impairment—Glyburide—type 2 diabetes mellitus	0.000564	0.00928	CcSEcCtD
Fluorometholone—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.000556	0.00914	CcSEcCtD
Fluorometholone—Eye disorder—Glyburide—type 2 diabetes mellitus	0.000547	0.009	CcSEcCtD
Fluorometholone—Dysgeusia—Bromocriptine—type 2 diabetes mellitus	0.000546	0.00898	CcSEcCtD
Fluorometholone—Vision blurred—Bromocriptine—type 2 diabetes mellitus	0.000525	0.00864	CcSEcCtD
Fluorometholone—Rash—Chlorpropamide—type 2 diabetes mellitus	0.000514	0.00845	CcSEcCtD
Fluorometholone—Rash—Tolazamide—type 2 diabetes mellitus	0.000514	0.00845	CcSEcCtD
Fluorometholone—Rash—Linagliptin—type 2 diabetes mellitus	0.000508	0.00836	CcSEcCtD
Fluorometholone—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.000508	0.00835	CcSEcCtD
Fluorometholone—Visual impairment—Gliclazide—type 2 diabetes mellitus	0.000507	0.00833	CcSEcCtD
Fluorometholone—Medroxyprogesterone Acetate—HSD3B2—type 2 diabetes mellitus	0.000495	0.0664	CrCbGaD
Fluorometholone—Rash—Acarbose—type 2 diabetes mellitus	0.000493	0.00811	CcSEcCtD
Fluorometholone—Dermatitis—Acarbose—type 2 diabetes mellitus	0.000493	0.00811	CcSEcCtD
Fluorometholone—Eye disorder—Gliclazide—type 2 diabetes mellitus	0.000491	0.00808	CcSEcCtD
Fluorometholone—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.000481	0.00791	CcSEcCtD
Fluorometholone—Vision blurred—Glyburide—type 2 diabetes mellitus	0.00048	0.0079	CcSEcCtD
Fluorometholone—Rash—Nateglinide—type 2 diabetes mellitus	0.000476	0.00782	CcSEcCtD
Fluorometholone—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000475	0.00782	CcSEcCtD
Fluorometholone—Pain—Glipizide—type 2 diabetes mellitus	0.000462	0.0076	CcSEcCtD
Fluorometholone—Conjunctivitis—Irbesartan—type 2 diabetes mellitus	0.000449	0.00739	CcSEcCtD
Fluorometholone—Pain—Sitagliptin—type 2 diabetes mellitus	0.00043	0.00707	CcSEcCtD
Fluorometholone—Conjunctivitis—Losartan—type 2 diabetes mellitus	0.000423	0.00695	CcSEcCtD
Fluorometholone—Rash—Repaglinide—type 2 diabetes mellitus	0.000412	0.00677	CcSEcCtD
Fluorometholone—Dysgeusia—Valsartan—type 2 diabetes mellitus	0.000412	0.00677	CcSEcCtD
Fluorometholone—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000411	0.00677	CcSEcCtD
Fluorometholone—Eye disorder—Metformin—type 2 diabetes mellitus	0.000411	0.00676	CcSEcCtD
Fluorometholone—Dysgeusia—Orlistat—type 2 diabetes mellitus	0.000407	0.00669	CcSEcCtD
Fluorometholone—Visual impairment—Irbesartan—type 2 diabetes mellitus	0.0004	0.00658	CcSEcCtD
Fluorometholone—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000398	0.00655	CcSEcCtD
Fluorometholone—Vision blurred—Valsartan—type 2 diabetes mellitus	0.000396	0.00652	CcSEcCtD
Fluorometholone—Vision blurred—Orlistat—type 2 diabetes mellitus	0.000392	0.00644	CcSEcCtD
Fluorometholone—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000389	0.0064	CcSEcCtD
Fluorometholone—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000389	0.00639	CcSEcCtD
Fluorometholone—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000381	0.00627	CcSEcCtD
Fluorometholone—Dysgeusia—Metformin—type 2 diabetes mellitus	0.000375	0.00616	CcSEcCtD
Fluorometholone—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000372	0.00611	CcSEcCtD
Fluorometholone—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00037	0.00609	CcSEcCtD
Fluorometholone—NR3C1—Transcription factor regulation in adipogenesis—IRS2—type 2 diabetes mellitus	0.000366	0.00859	CbGpPWpGaD
Fluorometholone—Conjunctivitis—Ramipril—type 2 diabetes mellitus	0.000363	0.00596	CcSEcCtD
Fluorometholone—Vision blurred—Metformin—type 2 diabetes mellitus	0.000361	0.00593	CcSEcCtD
Fluorometholone—CYP3A4—Aflatoxin B1 metabolism—GSTM1—type 2 diabetes mellitus	0.00036	0.00845	CbGpPWpGaD
Fluorometholone—NR3C1—Transcription factor regulation in adipogenesis—LEP—type 2 diabetes mellitus	0.000358	0.0084	CbGpPWpGaD
Fluorometholone—NR3C1—Adipogenesis—RETN—type 2 diabetes mellitus	0.000355	0.00833	CbGpPWpGaD
Fluorometholone—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.000354	0.00582	CcSEcCtD
Fluorometholone—CYP3A4—Oxidation by Cytochrome P450—CYB5R4—type 2 diabetes mellitus	0.000348	0.00818	CbGpPWpGaD
Fluorometholone—NR3C1—Circadian Clock—CPT1A—type 2 diabetes mellitus	0.000345	0.0081	CbGpPWpGaD
Fluorometholone—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—type 2 diabetes mellitus	0.000344	0.00806	CbGpPWpGaD
Fluorometholone—Rash—Glipizide—type 2 diabetes mellitus	0.000341	0.0056	CcSEcCtD
Fluorometholone—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.00034	0.0056	CcSEcCtD
Fluorometholone—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00034	0.0056	CcSEcCtD
Fluorometholone—NR3C1—Circadian Clock—NAMPT—type 2 diabetes mellitus	0.000338	0.00794	CbGpPWpGaD
Fluorometholone—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000333	0.00548	CcSEcCtD
Fluorometholone—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000323	0.00531	CcSEcCtD
Fluorometholone—NR3C1—Nuclear Receptors—AR—type 2 diabetes mellitus	0.000321	0.00755	CbGpPWpGaD
Fluorometholone—NR3C1—Circadian Clock—F7—type 2 diabetes mellitus	0.000321	0.00753	CbGpPWpGaD
Fluorometholone—Vision blurred—Losartan—type 2 diabetes mellitus	0.00032	0.00527	CcSEcCtD
Fluorometholone—Pain—Gliclazide—type 2 diabetes mellitus	0.000319	0.00525	CcSEcCtD
Fluorometholone—NR3C1—Transcription factor regulation in adipogenesis—IRS1—type 2 diabetes mellitus	0.000319	0.0075	CbGpPWpGaD
Fluorometholone—Rash—Glimepiride—type 2 diabetes mellitus	0.000318	0.00523	CcSEcCtD
Fluorometholone—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000318	0.00522	CcSEcCtD
Fluorometholone—Rash—Sitagliptin—type 2 diabetes mellitus	0.000317	0.00521	CcSEcCtD
Fluorometholone—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000317	0.00521	CcSEcCtD
Fluorometholone—NR3C1—Transcription factor regulation in adipogenesis—PPARG—type 2 diabetes mellitus	0.000312	0.00732	CbGpPWpGaD
Fluorometholone—CYP3A4—Tryptophan metabolism—AANAT—type 2 diabetes mellitus	0.000311	0.0073	CbGpPWpGaD
Fluorometholone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARGC1A—type 2 diabetes mellitus	0.000309	0.00726	CbGpPWpGaD
Fluorometholone—NR3C1—SIDS Susceptibility Pathways—KCNQ1—type 2 diabetes mellitus	0.000307	0.0072	CbGpPWpGaD
Fluorometholone—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000306	0.00504	CcSEcCtD
Fluorometholone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—type 2 diabetes mellitus	0.000305	0.00717	CbGpPWpGaD
Fluorometholone—NR3C1—Circadian Clock—SREBF1—type 2 diabetes mellitus	0.000302	0.00708	CbGpPWpGaD
Fluorometholone—NR3C1—AP-1 transcription factor network—ATF3—type 2 diabetes mellitus	0.000295	0.00691	CbGpPWpGaD
Fluorometholone—Pain—Orlistat—type 2 diabetes mellitus	0.00029	0.00477	CcSEcCtD
Fluorometholone—Rash—Bromocriptine—type 2 diabetes mellitus	0.000287	0.00472	CcSEcCtD
Fluorometholone—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000287	0.00471	CcSEcCtD
Fluorometholone—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000286	0.00469	CcSEcCtD
Fluorometholone—NR3C1—SIDS Susceptibility Pathways—ECE1—type 2 diabetes mellitus	0.000285	0.0067	CbGpPWpGaD
Fluorometholone—NR3C1—SIDS Susceptibility Pathways—G6PC—type 2 diabetes mellitus	0.000285	0.0067	CbGpPWpGaD
Fluorometholone—NR3C1—Adipogenesis—HNF1A—type 2 diabetes mellitus	0.000281	0.00659	CbGpPWpGaD
Fluorometholone—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000275	0.00452	CcSEcCtD
Fluorometholone—Rash—Glyburide—type 2 diabetes mellitus	0.000262	0.00431	CcSEcCtD
Fluorometholone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ATF3—type 2 diabetes mellitus	0.000262	0.00615	CbGpPWpGaD
Fluorometholone—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000262	0.00431	CcSEcCtD
Fluorometholone—NR3C1—Adipogenesis—MIF—type 2 diabetes mellitus	0.000259	0.00608	CbGpPWpGaD
Fluorometholone—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA6—type 2 diabetes mellitus	0.000258	0.00607	CbGpPWpGaD
Fluorometholone—NR3C1—Nuclear Receptor transcription pathway—AR—type 2 diabetes mellitus	0.000254	0.00596	CbGpPWpGaD
Fluorometholone—NR3C1—Regulation of nuclear SMAD2/3 signaling—HNF4A—type 2 diabetes mellitus	0.000253	0.00594	CbGpPWpGaD
Fluorometholone—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000253	0.00416	CcSEcCtD
Fluorometholone—Pain—Irbesartan—type 2 diabetes mellitus	0.000252	0.00415	CcSEcCtD
Fluorometholone—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.00025	0.00411	CcSEcCtD
Fluorometholone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—type 2 diabetes mellitus	0.000249	0.00584	CbGpPWpGaD
Fluorometholone—NR3C1—Regulation of Androgen receptor activity—AR—type 2 diabetes mellitus	0.000246	0.00578	CbGpPWpGaD
Fluorometholone—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—type 2 diabetes mellitus	0.000245	0.00575	CbGpPWpGaD
Fluorometholone—NR3C1—Nuclear Receptors—PPARA—type 2 diabetes mellitus	0.000244	0.00572	CbGpPWpGaD
Fluorometholone—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—type 2 diabetes mellitus	0.000242	0.00569	CbGpPWpGaD
Fluorometholone—Pain—Losartan—type 2 diabetes mellitus	0.000237	0.0039	CcSEcCtD
Fluorometholone—NR3C1—AP-1 transcription factor network—TIMP1—type 2 diabetes mellitus	0.000236	0.00553	CbGpPWpGaD
Fluorometholone—Rash—Gliclazide—type 2 diabetes mellitus	0.000235	0.00387	CcSEcCtD
Fluorometholone—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000235	0.00387	CcSEcCtD
Fluorometholone—NR3C1—Adipogenesis—PCK1—type 2 diabetes mellitus	0.000235	0.00552	CbGpPWpGaD
Fluorometholone—NR3C1—Circadian Clock—PPARGC1A—type 2 diabetes mellitus	0.000225	0.00529	CbGpPWpGaD
Fluorometholone—NR3C1—Regulation of Androgen receptor activity—SIRT1—type 2 diabetes mellitus	0.000225	0.00527	CbGpPWpGaD
Fluorometholone—NR3C1—Circadian Clock—AVP—type 2 diabetes mellitus	0.000222	0.00522	CbGpPWpGaD
Fluorometholone—CYP3A4—Estrogen metabolism—CYP1A2—type 2 diabetes mellitus	0.000221	0.00518	CbGpPWpGaD
Fluorometholone—NR3C1—AP-1 transcription factor network—TCF7L2—type 2 diabetes mellitus	0.000219	0.00515	CbGpPWpGaD
Fluorometholone—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000217	0.00357	CcSEcCtD
Fluorometholone—Rash—Valsartan—type 2 diabetes mellitus	0.000216	0.00356	CcSEcCtD
Fluorometholone—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000216	0.00355	CcSEcCtD
Fluorometholone—Rash—Orlistat—type 2 diabetes mellitus	0.000214	0.00352	CcSEcCtD
Fluorometholone—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000214	0.00351	CcSEcCtD
Fluorometholone—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—type 2 diabetes mellitus	0.000211	0.00496	CbGpPWpGaD
Fluorometholone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—type 2 diabetes mellitus	0.000207	0.00486	CbGpPWpGaD
Fluorometholone—CYP3A4—Xenobiotics—CYP2E1—type 2 diabetes mellitus	0.000205	0.00481	CbGpPWpGaD
Fluorometholone—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000204	0.00336	CcSEcCtD
Fluorometholone—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—type 2 diabetes mellitus	0.000203	0.00477	CbGpPWpGaD
Fluorometholone—CYP3A4—Xenobiotics—CYP1A2—type 2 diabetes mellitus	0.000203	0.00476	CbGpPWpGaD
Fluorometholone—Difluprednate—NR3C1—type 2 diabetes mellitus	0.000202	0.0271	CrCbGaD
Fluorometholone—NR3C1—Nuclear Receptors—PPARG—type 2 diabetes mellitus	0.000201	0.00473	CbGpPWpGaD
Fluorometholone—NR3C1—AP-1 transcription factor network—GJA1—type 2 diabetes mellitus	0.000199	0.00467	CbGpPWpGaD
Fluorometholone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—type 2 diabetes mellitus	0.000197	0.00463	CbGpPWpGaD
Fluorometholone—CYP3A4—Tamoxifen metabolism—CYP2E1—type 2 diabetes mellitus	0.000197	0.00463	CbGpPWpGaD
Fluorometholone—Rash—Metformin—type 2 diabetes mellitus	0.000197	0.00324	CcSEcCtD
Fluorometholone—Dermatitis—Metformin—type 2 diabetes mellitus	0.000197	0.00324	CcSEcCtD
Fluorometholone—Clocortolone—NR3C1—type 2 diabetes mellitus	0.000196	0.0263	CrCbGaD
Fluorometholone—CYP3A4—Tamoxifen metabolism—CYP1A2—type 2 diabetes mellitus	0.000195	0.00458	CbGpPWpGaD
Fluorometholone—NR3C1—Nuclear Receptor transcription pathway—PPARA—type 2 diabetes mellitus	0.000192	0.00452	CbGpPWpGaD
Fluorometholone—Rash—Irbesartan—type 2 diabetes mellitus	0.000186	0.00306	CcSEcCtD
Fluorometholone—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000186	0.00305	CcSEcCtD
Fluorometholone—Diflorasone—NR3C1—type 2 diabetes mellitus	0.000185	0.0249	CrCbGaD
Fluorometholone—Desonide—NR3C1—type 2 diabetes mellitus	0.000185	0.0249	CrCbGaD
Fluorometholone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—type 2 diabetes mellitus	0.000185	0.00435	CbGpPWpGaD
Fluorometholone—NR3C1—Circadian Clock—PPARA—type 2 diabetes mellitus	0.000181	0.00425	CbGpPWpGaD
Fluorometholone—Desoximetasone—NR3C1—type 2 diabetes mellitus	0.000181	0.0243	CrCbGaD
Fluorometholone—Loteprednol—NR3C1—type 2 diabetes mellitus	0.000179	0.024	CrCbGaD
Fluorometholone—Fludrocortisone—AR—type 2 diabetes mellitus	0.000176	0.0237	CrCbGaD
Fluorometholone—NR3C1—Circadian Clock—HIF1A—type 2 diabetes mellitus	0.000176	0.00414	CbGpPWpGaD
Fluorometholone—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—type 2 diabetes mellitus	0.000176	0.00412	CbGpPWpGaD
Fluorometholone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—type 2 diabetes mellitus	0.000175	0.00412	CbGpPWpGaD
Fluorometholone—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000175	0.00288	CcSEcCtD
Fluorometholone—Rash—Losartan—type 2 diabetes mellitus	0.000175	0.00288	CcSEcCtD
Fluorometholone—Dermatitis—Losartan—type 2 diabetes mellitus	0.000175	0.00287	CcSEcCtD
Fluorometholone—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—type 2 diabetes mellitus	0.000175	0.0041	CbGpPWpGaD
Fluorometholone—NR3C1—AP-1 transcription factor network—EDN1—type 2 diabetes mellitus	0.000174	0.00409	CbGpPWpGaD
Fluorometholone—NR3C1—Adipogenesis—NAMPT—type 2 diabetes mellitus	0.00017	0.00399	CbGpPWpGaD
Fluorometholone—CYP3A4—Estrogen metabolism—GSTM1—type 2 diabetes mellitus	0.000169	0.00397	CbGpPWpGaD
Fluorometholone—Fluoxymesterone—SHBG—type 2 diabetes mellitus	0.000166	0.0223	CrCbGaD
Fluorometholone—NR3C1—Transcription factor regulation in adipogenesis—TNF—type 2 diabetes mellitus	0.000166	0.00389	CbGpPWpGaD
Fluorometholone—Medrysone—NR3C1—type 2 diabetes mellitus	0.000164	0.0221	CrCbGaD
Fluorometholone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—type 2 diabetes mellitus	0.000162	0.0038	CbGpPWpGaD
Fluorometholone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—type 2 diabetes mellitus	0.000161	0.00378	CbGpPWpGaD
Fluorometholone—NR3C1—Nuclear Receptor transcription pathway—PPARG—type 2 diabetes mellitus	0.000159	0.00374	CbGpPWpGaD
Fluorometholone—Flumethasone Pivalate—NR3C1—type 2 diabetes mellitus	0.000156	0.0209	CrCbGaD
Fluorometholone—NR3C1—Adipogenesis—HMGA1—type 2 diabetes mellitus	0.000155	0.00363	CbGpPWpGaD
Fluorometholone—Halobetasol Propionate—NR3C1—type 2 diabetes mellitus	0.000153	0.0206	CrCbGaD
Fluorometholone—NR3C1—Adipogenesis—SREBF1—type 2 diabetes mellitus	0.000152	0.00356	CbGpPWpGaD
Fluorometholone—Rash—Ramipril—type 2 diabetes mellitus	0.00015	0.00247	CcSEcCtD
Fluorometholone—Dermatitis—Ramipril—type 2 diabetes mellitus	0.00015	0.00246	CcSEcCtD
Fluorometholone—NR3C1—SIDS Susceptibility Pathways—CPT1A—type 2 diabetes mellitus	0.00015	0.00352	CbGpPWpGaD
Fluorometholone—NR3C1—AP-1 transcription factor network—MMP1—type 2 diabetes mellitus	0.000147	0.00344	CbGpPWpGaD
Fluorometholone—NR3C1—SIDS Susceptibility Pathways—GCK—type 2 diabetes mellitus	0.000146	0.00343	CbGpPWpGaD
Fluorometholone—Fluoxymesterone—AR—type 2 diabetes mellitus	0.000146	0.0195	CrCbGaD
Fluorometholone—NR3C1—AP-1 transcription factor network—HIF1A—type 2 diabetes mellitus	0.000145	0.00341	CbGpPWpGaD
Fluorometholone—NR3C1—AP-1 transcription factor network—AGT—type 2 diabetes mellitus	0.000145	0.0034	CbGpPWpGaD
Fluorometholone—Medroxyprogesterone Acetate—SHBG—type 2 diabetes mellitus	0.000142	0.0191	CrCbGaD
Fluorometholone—Amcinonide—NR3C1—type 2 diabetes mellitus	0.000142	0.0191	CrCbGaD
Fluorometholone—Budesonide—NR3C1—type 2 diabetes mellitus	0.000142	0.0191	CrCbGaD
Fluorometholone—Fluticasone furoate—NR3C1—type 2 diabetes mellitus	0.00014	0.0187	CrCbGaD
Fluorometholone—NR3C1—Adipogenesis—ADIPOQ—type 2 diabetes mellitus	0.000139	0.00327	CbGpPWpGaD
Fluorometholone—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—type 2 diabetes mellitus	0.000136	0.0032	CbGpPWpGaD
Fluorometholone—Mometasone—NR3C1—type 2 diabetes mellitus	0.000135	0.0182	CrCbGaD
Fluorometholone—NR3C1—Circadian Clock—SERPINE1—type 2 diabetes mellitus	0.000135	0.00317	CbGpPWpGaD
Fluorometholone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—type 2 diabetes mellitus	0.000134	0.00315	CbGpPWpGaD
Fluorometholone—Rimexolone—NR3C1—type 2 diabetes mellitus	0.000134	0.018	CrCbGaD
Fluorometholone—NR3C1—Transcription factor regulation in adipogenesis—IL6—type 2 diabetes mellitus	0.000134	0.00314	CbGpPWpGaD
Fluorometholone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—type 2 diabetes mellitus	0.000133	0.00311	CbGpPWpGaD
Fluorometholone—NR3C1—Adipogenesis—SLC2A4—type 2 diabetes mellitus	0.000131	0.00308	CbGpPWpGaD
Fluorometholone—NR3C1—SIDS Susceptibility Pathways—SNAP25—type 2 diabetes mellitus	0.000131	0.00307	CbGpPWpGaD
Fluorometholone—NR3C1—Glucocorticoid receptor regulatory network—MMP1—type 2 diabetes mellitus	0.000129	0.00303	CbGpPWpGaD
Fluorometholone—Fluocinonide—NR3C1—type 2 diabetes mellitus	0.000126	0.017	CrCbGaD
Fluorometholone—Beclomethasone—NR3C1—type 2 diabetes mellitus	0.000126	0.017	CrCbGaD
Fluorometholone—Medroxyprogesterone Acetate—AR—type 2 diabetes mellitus	0.000125	0.0168	CrCbGaD
Fluorometholone—Fluocinolone Acetonide—NR3C1—type 2 diabetes mellitus	0.000123	0.0165	CrCbGaD
Fluorometholone—Alclometasone—NR3C1—type 2 diabetes mellitus	0.000123	0.0165	CrCbGaD
Fluorometholone—Clobetasol propionate—NR3C1—type 2 diabetes mellitus	0.000119	0.016	CrCbGaD
Fluorometholone—Fludrocortisone—NR3C1—type 2 diabetes mellitus	0.000119	0.016	CrCbGaD
Fluorometholone—Flunisolide—NR3C1—type 2 diabetes mellitus	0.000119	0.016	CrCbGaD
Fluorometholone—NR3C1—AP-1 transcription factor network—CCL2—type 2 diabetes mellitus	0.000119	0.0028	CbGpPWpGaD
Fluorometholone—NR3C1—Gene Expression—IGF2BP2—type 2 diabetes mellitus	0.000119	0.00279	CbGpPWpGaD
Fluorometholone—Paramethasone—NR3C1—type 2 diabetes mellitus	0.000118	0.0158	CrCbGaD
Fluorometholone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—type 2 diabetes mellitus	0.000117	0.00275	CbGpPWpGaD
Fluorometholone—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—type 2 diabetes mellitus	0.000115	0.0027	CbGpPWpGaD
Fluorometholone—NR3C1—Adipogenesis—PPARGC1A—type 2 diabetes mellitus	0.000113	0.00266	CbGpPWpGaD
Fluorometholone—Methylprednisolone—NR3C1—type 2 diabetes mellitus	0.000111	0.0149	CrCbGaD
Fluorometholone—Dexamethasone—CYP11A1—type 2 diabetes mellitus	0.000107	0.0143	CrCbGaD
Fluorometholone—CYP3A4—Tryptophan metabolism—CYP2E1—type 2 diabetes mellitus	0.000105	0.00247	CbGpPWpGaD
Fluorometholone—NR3C1—SIDS Susceptibility Pathways—GJA1—type 2 diabetes mellitus	0.000105	0.00246	CbGpPWpGaD
Fluorometholone—Clobetasol propionate—CYP1A2—type 2 diabetes mellitus	0.000105	0.014	CrCbGaD
Fluorometholone—CYP3A4—Tryptophan metabolism—CYP1A2—type 2 diabetes mellitus	0.000104	0.00244	CbGpPWpGaD
Fluorometholone—NR3C1—AP-1 transcription factor network—CDKN2A—type 2 diabetes mellitus	0.000104	0.00244	CbGpPWpGaD
Fluorometholone—NR3C1—SIDS Susceptibility Pathways—AR—type 2 diabetes mellitus	0.000104	0.00244	CbGpPWpGaD
Fluorometholone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—type 2 diabetes mellitus	0.000103	0.00242	CbGpPWpGaD
Fluorometholone—NR3C1—Adipogenesis—LPL—type 2 diabetes mellitus	0.000103	0.00242	CbGpPWpGaD
Fluorometholone—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—type 2 diabetes mellitus	0.000102	0.00239	CbGpPWpGaD
Fluorometholone—Hydrocortisone—SHBG—type 2 diabetes mellitus	0.000101	0.0136	CrCbGaD
Fluorometholone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—type 2 diabetes mellitus	9.9e-05	0.00232	CbGpPWpGaD
Fluorometholone—Fluoxymesterone—NR3C1—type 2 diabetes mellitus	9.87e-05	0.0133	CrCbGaD
Fluorometholone—NR3C1—Regulation of Androgen receptor activity—SRC—type 2 diabetes mellitus	9.82e-05	0.0023	CbGpPWpGaD
Fluorometholone—NR3C1—SIDS Susceptibility Pathways—GNB3—type 2 diabetes mellitus	9.79e-05	0.0023	CbGpPWpGaD
Fluorometholone—NR3C1—SIDS Susceptibility Pathways—PPARGC1A—type 2 diabetes mellitus	9.79e-05	0.0023	CbGpPWpGaD
Fluorometholone—NR3C1—SIDS Susceptibility Pathways—AVP—type 2 diabetes mellitus	9.65e-05	0.00227	CbGpPWpGaD
Fluorometholone—NR3C1—Adipogenesis—FAS—type 2 diabetes mellitus	9.41e-05	0.00221	CbGpPWpGaD
Fluorometholone—Triamcinolone—NR3C1—type 2 diabetes mellitus	9.39e-05	0.0126	CrCbGaD
Fluorometholone—NR3C1—Generic Transcription Pathway—NCOA6—type 2 diabetes mellitus	9.29e-05	0.00218	CbGpPWpGaD
Fluorometholone—NR3C1—Adipogenesis—PPARA—type 2 diabetes mellitus	9.11e-05	0.00214	CbGpPWpGaD
Fluorometholone—CYP3A4—Biological oxidations—MAT1A—type 2 diabetes mellitus	9.04e-05	0.00212	CbGpPWpGaD
Fluorometholone—NR3C1—Adipogenesis—HIF1A—type 2 diabetes mellitus	8.85e-05	0.00208	CbGpPWpGaD
Fluorometholone—Dexamethasone—NOS2—type 2 diabetes mellitus	8.84e-05	0.0119	CrCbGaD
Fluorometholone—NR3C1—Adipogenesis—IRS2—type 2 diabetes mellitus	8.83e-05	0.00207	CbGpPWpGaD
Fluorometholone—NR3C1—Adipogenesis—AGT—type 2 diabetes mellitus	8.82e-05	0.00207	CbGpPWpGaD
Fluorometholone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—type 2 diabetes mellitus	8.81e-05	0.00207	CbGpPWpGaD
Fluorometholone—NR3C1—Glucocorticoid receptor regulatory network—RELA—type 2 diabetes mellitus	8.81e-05	0.00207	CbGpPWpGaD
Fluorometholone—NR3C1—Adipogenesis—LEP—type 2 diabetes mellitus	8.64e-05	0.00203	CbGpPWpGaD
Fluorometholone—NR3C1—AP-1 transcription factor network—MMP9—type 2 diabetes mellitus	8.52e-05	0.002	CbGpPWpGaD
Fluorometholone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—type 2 diabetes mellitus	8.51e-05	0.002	CbGpPWpGaD
Fluorometholone—Prednisone—NR3C1—type 2 diabetes mellitus	8.51e-05	0.0114	CrCbGaD
Fluorometholone—Medroxyprogesterone Acetate—NR3C1—type 2 diabetes mellitus	8.47e-05	0.0114	CrCbGaD
Fluorometholone—CYP3A4—Tryptophan metabolism—CAT—type 2 diabetes mellitus	8.45e-05	0.00198	CbGpPWpGaD
Fluorometholone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—type 2 diabetes mellitus	8.42e-05	0.00198	CbGpPWpGaD
Fluorometholone—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—type 2 diabetes mellitus	8.4e-05	0.00197	CbGpPWpGaD
Fluorometholone—Fluticasone Propionate—NR3C1—type 2 diabetes mellitus	8.39e-05	0.0113	CrCbGaD
Fluorometholone—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—type 2 diabetes mellitus	8.36e-05	0.00196	CbGpPWpGaD
Fluorometholone—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—type 2 diabetes mellitus	8.31e-05	0.00195	CbGpPWpGaD
Fluorometholone—Budesonide—CYP3A4—type 2 diabetes mellitus	8.25e-05	0.0111	CrCbGaD
Fluorometholone—Fluticasone furoate—CYP3A4—type 2 diabetes mellitus	8.09e-05	0.0109	CrCbGaD
Fluorometholone—Prednisolone—NR3C1—type 2 diabetes mellitus	7.85e-05	0.0105	CrCbGaD
Fluorometholone—NR3C1—Adipogenesis—IRS1—type 2 diabetes mellitus	7.71e-05	0.00181	CbGpPWpGaD
Fluorometholone—Betamethasone—NR3C1—type 2 diabetes mellitus	7.69e-05	0.0103	CrCbGaD
Fluorometholone—NR3C1—SIDS Susceptibility Pathways—HIF1A—type 2 diabetes mellitus	7.65e-05	0.0018	CbGpPWpGaD
Fluorometholone—NR3C1—Adipogenesis—PPARG—type 2 diabetes mellitus	7.53e-05	0.00177	CbGpPWpGaD
Fluorometholone—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—type 2 diabetes mellitus	7.43e-05	0.00174	CbGpPWpGaD
Fluorometholone—NR3C1—Adipogenesis—INS—type 2 diabetes mellitus	7.38e-05	0.00173	CbGpPWpGaD
Fluorometholone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—type 2 diabetes mellitus	7.28e-05	0.00171	CbGpPWpGaD
Fluorometholone—NR3C1—Endoderm Differentiation—TGFB1—type 2 diabetes mellitus	7.19e-05	0.00169	CbGpPWpGaD
Fluorometholone—NR3C1—Adipogenesis—IGF1—type 2 diabetes mellitus	7.14e-05	0.00168	CbGpPWpGaD
Fluorometholone—Alclometasone—CYP3A4—type 2 diabetes mellitus	7.11e-05	0.00955	CrCbGaD
Fluorometholone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—type 2 diabetes mellitus	7.08e-05	0.00166	CbGpPWpGaD
Fluorometholone—NR3C1—AP-1 transcription factor network—TGFB1—type 2 diabetes mellitus	7.02e-05	0.00165	CbGpPWpGaD
Fluorometholone—Flunisolide—CYP3A4—type 2 diabetes mellitus	6.93e-05	0.0093	CrCbGaD
Fluorometholone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—type 2 diabetes mellitus	6.9e-05	0.00162	CbGpPWpGaD
Fluorometholone—Paramethasone—CYP3A4—type 2 diabetes mellitus	6.84e-05	0.00918	CrCbGaD
Fluorometholone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—type 2 diabetes mellitus	6.82e-05	0.0016	CbGpPWpGaD
Fluorometholone—NR3C1—Adipogenesis—SERPINE1—type 2 diabetes mellitus	6.78e-05	0.00159	CbGpPWpGaD
Fluorometholone—Methylprednisolone—CYP3A4—type 2 diabetes mellitus	6.45e-05	0.00866	CrCbGaD
Fluorometholone—NR3C1—Generic Transcription Pathway—HNF4A—type 2 diabetes mellitus	6.33e-05	0.00149	CbGpPWpGaD
Fluorometholone—Hydrocortisone—NR3C1—type 2 diabetes mellitus	6e-05	0.00806	CrCbGaD
Fluorometholone—Dexamethasone—ABCC2—type 2 diabetes mellitus	5.87e-05	0.00788	CrCbGaD
Fluorometholone—Triamcinolone—CYP3A4—type 2 diabetes mellitus	5.44e-05	0.00731	CrCbGaD
Fluorometholone—NR3C1—Generic Transcription Pathway—CTGF—type 2 diabetes mellitus	5.43e-05	0.00127	CbGpPWpGaD
Fluorometholone—Triamcinolone—PTGS2—type 2 diabetes mellitus	5.33e-05	0.00715	CrCbGaD
Fluorometholone—NR3C1—AP-1 transcription factor network—IL6—type 2 diabetes mellitus	5.29e-05	0.00124	CbGpPWpGaD
Fluorometholone—Prednisone—CYP3A4—type 2 diabetes mellitus	4.94e-05	0.00663	CrCbGaD
Fluorometholone—Medroxyprogesterone Acetate—CYP3A4—type 2 diabetes mellitus	4.91e-05	0.00659	CrCbGaD
Fluorometholone—Fluticasone Propionate—CYP3A4—type 2 diabetes mellitus	4.86e-05	0.00653	CrCbGaD
Fluorometholone—NR3C1—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	4.75e-05	0.00112	CbGpPWpGaD
Fluorometholone—NR3C1—Generic Transcription Pathway—NOTCH2—type 2 diabetes mellitus	4.7e-05	0.0011	CbGpPWpGaD
Fluorometholone—NR3C1—Glucocorticoid receptor regulatory network—IL6—type 2 diabetes mellitus	4.66e-05	0.00109	CbGpPWpGaD
Fluorometholone—CYP3A4—Biological oxidations—MTR—type 2 diabetes mellitus	4.59e-05	0.00108	CbGpPWpGaD
Fluorometholone—Prednisolone—CYP3A4—type 2 diabetes mellitus	4.55e-05	0.00611	CrCbGaD
Fluorometholone—Dexamethasone—NR3C1—type 2 diabetes mellitus	4.47e-05	0.00601	CrCbGaD
Fluorometholone—NR3C1—Gene Expression—NCOA6—type 2 diabetes mellitus	4.47e-05	0.00105	CbGpPWpGaD
Fluorometholone—Betamethasone—CYP3A4—type 2 diabetes mellitus	4.46e-05	0.00598	CrCbGaD
Fluorometholone—CYP3A4—Biological oxidations—CYP11A1—type 2 diabetes mellitus	4.44e-05	0.00104	CbGpPWpGaD
Fluorometholone—NR3C1—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	4.44e-05	0.00104	CbGpPWpGaD
Fluorometholone—NR3C1—Generic Transcription Pathway—AR—type 2 diabetes mellitus	4.39e-05	0.00103	CbGpPWpGaD
Fluorometholone—CYP3A4—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	4.38e-05	0.00103	CbGpPWpGaD
Fluorometholone—Betamethasone—PTGS2—type 2 diabetes mellitus	4.36e-05	0.00586	CrCbGaD
Fluorometholone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—type 2 diabetes mellitus	4.34e-05	0.00102	CbGpPWpGaD
Fluorometholone—Prednisone—ALB—type 2 diabetes mellitus	4.3e-05	0.00578	CrCbGaD
Fluorometholone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—type 2 diabetes mellitus	4.3e-05	0.00101	CbGpPWpGaD
Fluorometholone—NR3C1—Adipogenesis—TGFB1—type 2 diabetes mellitus	4.28e-05	0.001	CbGpPWpGaD
Fluorometholone—Dexamethasone—CYP2E1—type 2 diabetes mellitus	4.12e-05	0.00553	CrCbGaD
Fluorometholone—NR3C1—Generic Transcription Pathway—CDKN2B—type 2 diabetes mellitus	4.04e-05	0.000949	CbGpPWpGaD
Fluorometholone—NR3C1—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	4.03e-05	0.000946	CbGpPWpGaD
Fluorometholone—NR3C1—Adipogenesis—TNF—type 2 diabetes mellitus	4e-05	0.000938	CbGpPWpGaD
Fluorometholone—CYP3A4—Biological oxidations—CYP2E1—type 2 diabetes mellitus	3.67e-05	0.000861	CbGpPWpGaD
Fluorometholone—CYP3A4—Biological oxidations—CYP1A2—type 2 diabetes mellitus	3.63e-05	0.000851	CbGpPWpGaD
Fluorometholone—CYP3A4—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	3.62e-05	0.000849	CbGpPWpGaD
Fluorometholone—CYP3A4—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	3.58e-05	0.000839	CbGpPWpGaD
Fluorometholone—Hydrocortisone—CYP3A4—type 2 diabetes mellitus	3.48e-05	0.00467	CrCbGaD
Fluorometholone—NR3C1—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	3.45e-05	0.000811	CbGpPWpGaD
Fluorometholone—NR3C1—Generic Transcription Pathway—PPARA—type 2 diabetes mellitus	3.32e-05	0.000781	CbGpPWpGaD
Fluorometholone—NR3C1—Adipogenesis—IL6—type 2 diabetes mellitus	3.23e-05	0.000757	CbGpPWpGaD
Fluorometholone—NR3C1—Gene Expression—HNF4A—type 2 diabetes mellitus	3.05e-05	0.000715	CbGpPWpGaD
Fluorometholone—NR3C1—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	2.79e-05	0.000654	CbGpPWpGaD
Fluorometholone—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	2.78e-05	0.000652	CbGpPWpGaD
Fluorometholone—NR3C1—Generic Transcription Pathway—PPARG—type 2 diabetes mellitus	2.75e-05	0.000645	CbGpPWpGaD
Fluorometholone—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	2.74e-05	0.000643	CbGpPWpGaD
Fluorometholone—NR3C1—Gene Expression—PSMD6—type 2 diabetes mellitus	2.66e-05	0.000625	CbGpPWpGaD
Fluorometholone—NR3C1—Gene Expression—DNMT1—type 2 diabetes mellitus	2.66e-05	0.000625	CbGpPWpGaD
Fluorometholone—NR3C1—Gene Expression—CTGF—type 2 diabetes mellitus	2.61e-05	0.000614	CbGpPWpGaD
Fluorometholone—Dexamethasone—CYP3A4—type 2 diabetes mellitus	2.59e-05	0.00348	CrCbGaD
Fluorometholone—Dexamethasone—PTGS2—type 2 diabetes mellitus	2.54e-05	0.00341	CrCbGaD
Fluorometholone—NR3C1—Generic Transcription Pathway—SERPINE1—type 2 diabetes mellitus	2.48e-05	0.000581	CbGpPWpGaD
Fluorometholone—NR3C1—Gene Expression—NOTCH2—type 2 diabetes mellitus	2.26e-05	0.000532	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	2.12e-05	0.000497	CbGpPWpGaD
Fluorometholone—NR3C1—Gene Expression—AR—type 2 diabetes mellitus	2.11e-05	0.000496	CbGpPWpGaD
Fluorometholone—NR3C1—Gene Expression—CDKN2B—type 2 diabetes mellitus	1.95e-05	0.000457	CbGpPWpGaD
Fluorometholone—NR3C1—Gene Expression—SIRT1—type 2 diabetes mellitus	1.93e-05	0.000452	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.85e-05	0.000435	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.85e-05	0.000435	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.76e-05	0.000412	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.76e-05	0.000412	CbGpPWpGaD
Fluorometholone—NR3C1—Gene Expression—PPP2CA—type 2 diabetes mellitus	1.7e-05	0.000399	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.68e-05	0.000393	CbGpPWpGaD
Fluorometholone—NR3C1—Gene Expression—PPARA—type 2 diabetes mellitus	1.6e-05	0.000376	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.55e-05	0.000363	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.55e-05	0.000363	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.49e-05	0.000351	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.49e-05	0.000351	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.49e-05	0.000351	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.49e-05	0.000351	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.49e-05	0.000351	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.45e-05	0.000339	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.37e-05	0.000321	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.37e-05	0.000321	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.33e-05	0.000312	CbGpPWpGaD
Fluorometholone—NR3C1—Gene Expression—PPARG—type 2 diabetes mellitus	1.32e-05	0.000311	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	1.27e-05	0.000298	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	1.27e-05	0.000298	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	1.27e-05	0.000298	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	1.22e-05	0.000286	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	1.22e-05	0.000286	CbGpPWpGaD
Fluorometholone—NR3C1—Gene Expression—SERPINE1—type 2 diabetes mellitus	1.19e-05	0.00028	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	1.17e-05	0.000275	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	1.17e-05	0.000275	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	1.15e-05	0.00027	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	1.13e-05	0.000266	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	1.13e-05	0.000266	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	1.13e-05	0.000266	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	1.06e-05	0.00025	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	9.96e-06	0.000234	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	9.62e-06	0.000226	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	9.62e-06	0.000226	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	9.62e-06	0.000226	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	9.62e-06	0.000226	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	9.22e-06	0.000217	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	8.58e-06	0.000201	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	8.01e-06	0.000188	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	7.84e-06	0.000184	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	7.84e-06	0.000184	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	7.69e-06	0.000181	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	7.64e-06	0.000179	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	7.64e-06	0.000179	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	7.64e-06	0.000179	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	7.6e-06	0.000178	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	7.46e-06	0.000175	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	7.37e-06	0.000173	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	6.86e-06	0.000161	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	6.86e-06	0.000161	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	6.86e-06	0.000161	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	6.73e-06	0.000158	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	6.67e-06	0.000157	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	6.53e-06	0.000153	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	6.27e-06	0.000147	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	6.2e-06	0.000146	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	6.2e-06	0.000146	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	5.94e-06	0.00014	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	5.94e-06	0.00014	CbGpPWpGaD
Fluorometholone—NR3C1—Gene Expression—AKT1—type 2 diabetes mellitus	5.23e-06	0.000123	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.12e-06	0.00012	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	5.12e-06	0.00012	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	5.1e-06	0.00012	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	5.03e-06	0.000118	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	4.88e-06	0.000115	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	4.75e-06	0.000112	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	4.66e-06	0.000109	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	4.57e-06	0.000107	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	4.55e-06	0.000107	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	4.43e-06	0.000104	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	4.38e-06	0.000103	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	4.2e-06	9.86e-05	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	4.12e-06	9.67e-05	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	3.99e-06	9.37e-05	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	3.92e-06	9.21e-05	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	3.91e-06	9.18e-05	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	3.86e-06	9.07e-05	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	3.41e-06	7.99e-05	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	3.34e-06	7.84e-05	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	3.06e-06	7.19e-05	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.93e-06	6.88e-05	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.93e-06	6.88e-05	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.68e-06	6.29e-05	CbGpPWpGaD
Fluorometholone—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.35e-06	3.16e-05	CbGpPWpGaD
